Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study
Chang Kyung Kang, Nak Hyun Kim, Chung Jong Kim, Gi eun Rhie, Su Kyoung Jo, Misun Ahn, Jieun Kang, Pyoeng Gyun Choe, Wan Beom Park, Nam Joong Kim, Myoung don Oh
Research output: Contribution to journal › Article › peer-review
6Scopus
citations
Fingerprint
Dive into the research topics of 'Immunogenicity and safety of a novel recombinant protective antigen anthrax vaccine (GC1109), a randomized, single-blind, placebo controlled phase II clinical study'. Together they form a unique fingerprint.